Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

26.21 +0.41 (+1.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences Inc

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
32 33 Next >
Why Cassava Sciences Stock Is Soaring After Hours
Cassava Sciences Inc (NASDAQ: SAVA) shares are trading higher in Tuesday's after-hours session after new filings showed recent insider buying.  
Via Benzinga
CASSAVA SCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Cassava Sciences, Inc. - SAVA
From Kahn Swick & Foti, LLC
Via Business Wire
What Is Going on With Cassava Sciences (SAVA) Stock Today?
Cassava Sciences is moving higher on the day, as we have a "risk-on" rally in names like SAVA stock. Can the momentum last? 
Via InvestorPlace
Cassava Sciences: Q2 Earnings Insights
  Cassava Sciences (NASDAQ:SAVA) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Thursday, 7/28, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Cassava (SAVA) Stock Falls 30% on Report of Criminal Probe
SAVA stock is tumbling 30% in pre-market trading on a report that the Justice Department had launched a criminal probe of the company. 
Via InvestorPlace
Cassava Sciences Shares Plunge After Criminal Investigation Report
Via Benzinga
10 Stocks to Sell Before They Die
As the U.S. continues to struggle with stagflation, it’s becoming more important than ever to avoid pitfalls. 
Via InvestorPlace
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati... 
Via Benzinga
Dow Rises 150 Points As Fed Boosts Rates By 0.75 Percentage Points
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
Cassava Sciences Responds to Media Reports
From Cassava Sciences, Inc.
Via GlobeNewswire
Big Tech Powers Stocks Higher Ahead of Fed Decision
The major indexes are on the rise midday, ahead of the Fed's highly anticipated interest rate decision. 
Via Talk Markets
Sherwin-Williams, Kraft Heinz And Some Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Nasdaq Jumps Over 300 Points; Boeing Posts Wider-Than-Expected Loss
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday. 
Via Benzinga
GOOG Stock Pops as Alphabet Earnings Report Shows Strong Ad Revenue
Alphabet (GOOG,GOOGL) stock is on the rise Wednesday as investors react to the tech giant's earnings report for the second quarter of 2022. 
Via InvestorPlace
Spotify (SPOT) Stock Gains on Impressive User Growth
Spotify (SPOT) stock is on the rise Wednesday as investors react to a strong earnings report for the second quarter of 2022. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 83 companies set new 52-week lows. 
Via Benzinga
Why U.S. Stocks Are Trading Higher Ahead Of Fed Decision; Alphabet Earnings Miss Views
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 250 points on Wednesday. 
Via Benzinga
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital... 
Via Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27
Reuters Monkeypox Emergency Could Last Months, According To Experts 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on! 
Via InvestorPlace
Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session
Gainers Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022. 
Via Benzinga
7 Meme Stocks Trading at a Massive Discount Right Now
'Meme mania' has long since passed, but there may be an opportunity with these seven meme stocks trading at a discount right now. 
Via InvestorPlace
These Biotechs Are Reportedly Reinvigorating Alzheimer's Disease Research With Novel Drugs That Push Beyond Traditional Approaches
More than 55 million people worldwide have dementia — with about 60% to 70% of those cases resulting from Alzheimer’s disease — and that number is expected to triple by 2050. 
Via Benzinga
CASSAVA SCIENCES INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Cassava Sciences, Inc. - SAVA
From Kahn Swick & Foti, LLC
Via Business Wire
R&D Efforts for Central Nervous System (CNS) Therapeutics Have Resulted in Hopeful Novel Drug-Delivery Solutions
Palm Beach, FL – June 29 2022 – FinancialNewsMedia.com News Commentary – In the central nervous system (CNS) therapeutics market, large and small pharmaceutical companies are highly investing in the... 
Via FinancialNewsMedia
Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It
Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.